FindTrial
Sign In

Prevalence of anti-red blood cell alloantibodies in thalassemia patients receiving regular blood transfusions

Prevalence of Alloantibodies in Transfusion dependent Thalassemia patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/066548
Enrollment
90
Registered
2024-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D569- Thalassemia, unspecified

Interventions

Intervention1: Not applicable: Not applicable Control Intervention1: Not applicable: Not applicable

Sponsors

Sunil Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with thalassemia dependent on regular blood transfusion.

Exclusion criteria

Exclusion criteria: Patients diagnosed with thalassemia not dependent on regular blood transfusion.

Design outcomes

Primary

MeasureTime frame
To study the frequency of alloimmunization in patients diagnosed with thalassemia dependent on regular blood transfusions.Timepoint: At baseline—

Secondary

MeasureTime frame
To correlate the frequency of alloimmunization in transfusion dependent thalassemia patients with the red blood cell requirementTimepoint: At baseline—

Countries

India

Contacts

Public ContactSunil Kumar

Lok Nayak Hospital

nehaparashar127@gmail.com9910306518

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026